Financial Year |
June 30 2021 |
Monetary Funds |
138,310,745.14 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
336,947.13 |
Accounts Receivable |
74,745,565.25 |
Advances to Suppliers |
91,232,370.62 |
Other Receivables |
2,846,159.79 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
104,832,866.34 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
10,000,000.00 |
Other Current Assets |
6,924,732.27 |
Total Current Assets |
429,229,386.54 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
6,375,327.07 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,857,154.53 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
1,063,864.49 |
Deferred Income Tax Assets |
9,145,645.84 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
75,752,353.76 |
Total Assets |
504,981,740.30 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
59,476,600.38 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
4,008,994.63 |
Taxes Payable |
1,171,096.41 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
8,173,335.56 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,865,459.70 |
Other Current Liabilities |
90,170.83 |
Sub-Total of Current Liabilities |
88,973,931.54 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,414,539.42 |
Total Liabilities |
90,388,470.96 |
Paid-In Capital(Or Share Stock) |
54,029,937.00 |
Capital Surplus |
193,837,027.53 |
Surplus Reserve |
14,802,743.83 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
152,509,394.37 |
Minority Stockholder's Interest |
731,666.61 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
413,861,602.73 |
Owner's Equity(Stockholder's Equity) |
414,593,269.34 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
504,981,740.30 |